Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer

Bayne, Lauren J., Beatty, Gregory L., Jhala, Nirag, Clark, Carolyn E., Rhim, Andrew D., Stanger, Ben Z., Vonderheide, Robert H.·2012·Cancer Cell
DOI 10.1016/j.ccr.2012.04.025

Cited by (952)

Items 801–900 of 952

  1. The present and future of systemic and microenvironment-targeted therapy for pancreatic adenocarcinoma
    Arnav Mehta, William L. Hwang, Colin D. Weekes · 2020 · Annals of Pancreatic Cancer
  2. Methods for Analysis of the Immune System in Mouse Cancer Models
    Lauren J. Bayne, Robert H. Vonderheide · 2013 · Cold Spring Harbor Protocols
  3. Fusobacterium nucleatum induces pancreatic cancer cell proliferation and migration by regulating host autocrine and paracrine signaling
    Barath Udayasuryan, Tam T. D. Nguyen, Ariana Umaña, Raffae N. Ahmad, LaDeidra Monét Roberts, Polina Sobol, Stephen D. Jones, Jennifer M. Munson, Daniel Joseph Slade, Scott S. Verbridge · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Therapeutic Interruption of T Cell Development Generates High-Affinity T Cells That Escape Exhaustion and Improve Cancer Immunotherapy
    Erica Dhuey, Olivia Oldridge, Roshan Ravishankar, Hannah Dada, Yongjun Yu, Mark Stuart Anderson, Andy J. Minn · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Therapeutic Implications of UVB Irradiation in Cancer by Enhancing Anti‐Tumor Immunity†
    Bilal Bin Hafeez, Ed Wong Alvarado, Dae Joon Kim · 2022 · Photochemistry and Photobiology
  6. Immunotherapy for Pancreatic Cancer
    Yoshiaki Sunami, Simon Rieder, Patrick Michl, Jorg H. Kleeff · 2025 · Springer eBooks
  7. OX-40 signaling promotes tumorigenesis in CTCL by regulating ERK activation
    Evangelia Papadavid, Fani Karagianni, Eleni‐Kyriaki Vetsika, Sara Valero-Dıáz, Saire Edith Córdova-Hernández, Christos Daniil, Christina Piperi, Berta Casar · 2025 · Frontiers in Immunology
  8. Context defines precision: rethinking KRAS inhibition in oncology
    Serena Marchiò · 2026 · npj Precision Oncology
  9. Integrated Single-Cell Transcriptomics Identifies γδ T-Cell Heterogeneity and a Candidate HLA-E–NKG2A Regulatory Axis in Pancreatic Ductal Adenocarcinoma
    Saikat Mandal, Shirin R. Hasan, Arkadeep Dhali, Manideepa Maji · 2026 · Cancers
  10. YBX1 takes actions on triggering M2-like polarization of macrophages and stabilizing CXCL8 mRNA to exhibit its metastatic potential in bladder cancer
    Huihui Yang, Chuanchi Zhou, Zheng Zhou, Fan Zhang, Liang Tong · 2026 · International Immunopharmacology
  11. Quiescent tumor cells shape the immunosuppressive microenvironment in pancreatic cancer
    Bryan McClellan, Q. Wang, Kyaw Lwin Aung, William H. Matsui · 2026 · Nature Communications
  12. Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy
    Jaehyun Lee, Kai-Ting Yang, C. Nowicki, Wei Liu, Kang-Di Li, Emile Z. Naccasha, Zhi-Chen Sun, Yang-Bo Fu, H. Liang, R. Weichselbaum et al. · 2026 · Science Advances
  13. Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer
    Yen Thi Minh Nguyen, Marc Pfefferlé, Juhyun Oh, G. G. Simpson, S. A. Walker, Shingo Noguchi, Christopher S. Garris, Riley J. Deutsch-Williams, P. Wirapati, Federico De Stefano et al. · 2026 · Cell Reports Medicine
  14. KRAS-driven cytokine–metabolic crosstalk shapes immune exclusion in pancreatic ductal adenocarcinoma
    Chengjun Huang, Gang Mai, Yu Li, Hang Liu, Wei Huang · 2026 · Frontiers in Genetics
  15. CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer
    Qiang Li, Megan T. Hoffman, Jung-Ho Chun, Brendan D. Parent, Felix Hambitzer, Frank Peprah, Courtney T.S. Kureshi, Birkley S. Lim, Eugena Chang, Michael J. Walsh et al. · 2026 · Cell
  16. Strategies to Target Tumor Immunosuppression
    Oana Draghiciu, Hans W. Nijman, Toos Daemen · 2014 · Springer eBooks
  17. Regulatory T Cells and Th17 Cells in Cancer Microenvironment
    Chang H. Kim · 2014 · Springer eBooks
  18. Suppressing the rejection of pancreatic tumours
    Gemma K. Alderton · 2012 · Nature reviews. Immunology
  19. Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness
    Giuseppe Di Caro, Giovanni Francesco Castino, Francesca Bergomas, Nina Cortese, Maurizio Chiriva‐Internati, Fabio Grizzi, Federica Marchesi · 2014 · Expert Review of Anticancer Therapy
  20. Suppressing the rejection of pancreatic tumours
    Gemma K. Alderton · 2012 · Nature reviews. Cancer
  21. Myelomonocytic Subsets in Tumor Microenvironment
    Jo A. Van Ginderachter · 2014 · Springer eBooks
  22. Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications
    Kathleen A. Boyle, Michael A. James, Susan Tsai, Douglas B. Evans, Michael B. Dwinell · 2017 · Springer eBooks
  23. Pancreatic Carcinogenesis
    Valentin Taucher, Johannes Haybaeck · 2017 · Springer eBooks
  24. Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications
    Kathleen A. Boyle, Michael A. James, Susan Tsai, Douglas B. Evans, Michael B. Dwinell · 2018 · Springer eBooks
  25. Cancer and the science of innate immunity
    Melanie R. Rutkowski · 2023 · Elsevier eBooks
  26. Molecular cloning, recombinant expression and characterization of GMCSF from the rhesus monkey, Macaca mulatta.
    Ze Tao, Hao Yang, Dian-Long Jia, L. Wan, Jing-Qiu Cheng, Xiao-Feng Lu · 2013 · Developmental and Comparative Immunology
  27. Pancreatic cancer vaccine: a unique potential therapy
    Francesco Novelli, Moitza Principe, Paola Cappello · 2015 · Gastrointestinal Cancer Targets and Therapy
  28. Molecular pathogenesis of pancreatic ductal adenocarcinoma
    Sangeetha N. Kalimuthu, Faiyaz Notta · 2016 · Diagnostic histopathology
  29. Tumor-Associated Myeloid Cells in Cancer Progression
    Tamara Gulić, Rita Silva-Gomes, Sadaf Davoudian, Marina Sironi, Paola Allavena, Alberto Mantovani, Barbara Bottazzi · 2020 · Springer eBooks
  30. Targeted delivery and reprogramming of myeloid-derived suppressor cells (MDSCs) in cancer
    Hiroshi Katoh · 2021 · Elsevier eBooks
  31. Tumor-targeted delivery of childhood vaccine recall antigens by attenuated Listeria reduces pancreatic cancer
    Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe‐Tintaya, Arthee Jahangir, Ankur S. Patel, Kiran Meena, Rodrigo Alberto Alves da Silva, Madeline Friedman, Steven K. Libutti, Ziqiang Yuan et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  32. MDSCs IN COVID-19 Why should we care?
    Carlos Rodríguez · 2020
  33. Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice
    Yi Liu, Yasunori Deguchi, Daoyan Wei, Micheline J. Moussalli, Donghui Li, Huamin Wang, Lovie Ann Valentin, Jennifer K. Colby, Fuyao Liu, Jing Wang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Activated regulatory T-cells, dysfunctional and senescent T-cells dominate the microenvironment of pancreatic cancer
    Shivan Sivakumar, Enas Abu‐Shah, David Ahern, Edward H. Arbe-Barnes, Nagina Mangal, Srikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz, Michael Silva et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Immuntherapie des Pankreaskarzinoms
    Jonathan Ellermeier · 2013 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  36. External stimuli-responsive nanomedicine for cancer immunotherapy
    Liqian Niu, Eungyo Jang, Ai Lin Chin, Rong Tong · 2021 · Elsevier eBooks
  37. CIS calibrates GM-CSF signalling strength to regulate macrophage polarization via a STAT5-IRF8 axis
    Shengbo Zhang, Jai Rautela, Naiara G. Bediaga, Tatiana B. Kolesnik, Yue You, Laura F. Dagley, Justin Bedő, Hanqing Wang, Li Jun Sun, Robyn M. Sutherland et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Cancer cell CCR2 orchestrates suppression of the adaptive immune response
    MR Fein, X He, AS Almeida, Emilis Bružas, Arnaud Pommier, Ruoqing Yan, Anaïs Eberhardt, D T Fearon, L Van Aelst, JE Wilkinson et al. · 2020 · immuneACCESS
  39. Targeting Myeloid Protein Kinase C Signaling to Overcome Immune Suppression and Improve Immunotherapy in Cancer
    Mehdi Chaib · 2022
  40. Immunotherapy for ovarian cancer is improved by tumor-targeted delivery of a neoantigen surrogate
    Lauren Scanlon, Lisa R. Gabor, Olivia R Khouri, Shahbaz Ahmad, Evan Levy, Elizabeth Buckley, Ariene Ouedraogo, Dennis Yi‐Shin Kuo, Ken Yu Lin, Nicole Suzanne Nevadunsky et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  41. ecDNA-driven oncogene super-expressors shape immunoevasive tumor microenvironment
    Kailiang Qiao, Qing‐Lin Yang, Tuo Li, Xiongfeng Chen, Zeynep Yazgan, Yoon Jung Kim, Collin Gilbreath, Jun Yi Stanley Lim, Yipeng Xie, Xiaohui Sun et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Pancreatic Inflammation and Carcinogenesis
    Constantinos P. Zambirinis and George Miller · 2015
  43. Latent Regulatory Programs Generate Synthetic T Cell States with Enhanced Therapeutic Potential
    Brandon M. Pratt, Genevieve Nicole Mullins, Nolan James Brown, William D. Green, Jennifer L. Modliszewski, Fucong Xie, Lara van Rooyen, Vasyl Zhabotynsky, Alexander N. Jambor, Gabrielle Heather Cannon et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  44. The Biology of K-Ras Signaling Pathways in Pancreatic Cancer
    Helen Court, Mark R. Philips, Dafna Bar‐Sagi · 2013 · Springer eBooks
  45. Induction of T cell immunity overcomes resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic cancer
    Rafael Winograd · 2015 · ScholarlyCommons (University of Pennsylvania)
  46. The Molecular Frame of Pancreatic Carcinogenesis
    Elisabeth Heßmann, Sandra Baumgart, NM Chen, Shiv K. Singh, Garima Singh, Alex König, Albrecht Neeße, Volker Ellenrieder · 2014 · InTech eBooks
  47. Análise do envolvimento do receptor de quimiocinas - CCR5 - na migração de células T reguladoras: correlação com o desenvolvimento de carcinoma espinocelular
    Carine Ervolino de Oliveira · 2013
  48. The role of GM-CSF in pancreatic cancer unveiled
    Claire Greenhill · 2012 · Nature Reviews Gastroenterology & Hepatology
  49. Development of Resistance to Targeted Therapy: Preclinical Findings and Clinical Relevance
    James Walter Mier, Rupal Satish Bhatt, David J. Panka, Michael B. Atkins · 2014 · Springer eBooks
  50. Controversies in Neoplastic Myeloplasia
    James E. Talmadge · 2016 · SpringerBriefs in immunology
  51. 膵癌：発生・進展の分子機構
    佐藤 賢一 · 2013 · 日本消化機病學會雜誌. 乙
  52. Immature Myeloid Cells Promote Tumor Formation Via Non-Suppressive Mechanism
    Myrna L. Ortiz · 2014 · Digital Commons - University of South Florida (University of South Florida)
  53. Oncogenic KRAS and the Inflammatory Micro-Environment in Pancreatic Cancer
    Hui-Hua Chang, Andrea Schmidt, Guido Eibl · 2016 · Elsevier eBooks
  54. Pancreatic Cancer Fostered Immunosuppression Privileges Tumor Growth and
    Elisa Gnatta, Mario Plebani, Daniela Basso · 2014
  55. PD1 and PD-L1 Immune Checkpoint Inhibitors in Gastrointestinal Cancer
    Eirini Pectasides, David F. McDermott · 2017 · Springer eBooks
  56. The Role of Semaphorin 5A in Pancreatic Cancer Progression and Metastasis
    Sugandha Saxena · 2017 · DigitalCommons@UNMC
  57. COMBINATION IMMUNOTHERAPY TARGETING IMMUNOSUPPRESSIVE SIGNALS IN THE TUMOR MICROENVIRONMENT PREVENTS CANCER PROGRESSION IN BREAST AND PANCREATIC CANCER
    Bridget P. Keenan · 2015
  58. The ontogeny of inflammatory macrophages and monocyte-derived dendritic cells
    Shinelle Menezes · 2017 · Research Portal (King's College London)
  59. Immunomodulation and Vaccination with RHDV VLP
    Braeden Donaldson · 2017 · Otago University Research Archive (University of Otago)
  60. Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials
    Maulik R Patel, Sandip Pravin Patel, Razelle Kurzrock · 2017 · Current cancer research
  61. Pancreatic Adenocarcinoma: Current Therapies and Challenges
    Myron R. Szewczuk · 2017 · Advanced Research in Gastroenterology & Hepatology
  62. The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer
    Elena Niccolai, Antonio Taddei, Federica Ricci, Maria Novella Ringressi, Amedeo Amedei · 2017 · EMJ Oncology
  63. Adenocarcinoma of the Pancreas
    Quyen D. Chu, Erkut Hasan Borazanci, Roger H. Kim, Guillermo Pablo Sangster · 2018
  64. Immunotherapy for Pancreatic Cancer
    Adrian Gerard Murphy, Elizabeth M. Jaffee, Lei Zheng · 2018
  65. REOVIRUS-DRIVEN MYELOID CELLS IN ONCOLYTIC VIRUS THERAPY AND INFECTION
    Derek R. Clements · 2018 · DalSpace (Dalhousie University)
  66. Intratumoral STING Activation Sensitizes Poorly Immunogenic Cancers to Checkpoint Blockade Immunotherapy
    Casey R. Ager · 2018 · Digital Commons-TMC (Texas Medical Center)
  67. KANSER GELİŞİMİNDE İNFLAMASYONUN ROLÜ
    Işıl Yıldırım · 2019 · ANADOLU UNIVERSITY JOURNAL OF SCIENCE AND TECHNOLOGY –C Life Sciences and Biotechnology
  68. Dynamic Regulation Of The Bone Marrow Myeloid Compartment Under Post-Acute/Chronic Inflammatory Conditions
    Courtney D Culpepper · 2022 · Digital Archive @ GSU
  69. Systemic Inflammation Scores Predict the Activity of First-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
    Giuseppe A. Colloca, Antonella Venturino, Domenico Guarneri · 2020 · Cancer Investigation
  70. Exercise-Induced Engagement of the IL-15/IL15Rα axis Promotes Anti-Tumor Immunity
    Dafna Bar‐Sagi, Emma Kurz, Tanner C. Dalton, Sorin A. A. Shadaloey, Emily Vucic, Rafael Winograd, Carolina Alcantara Hirsch · 2021 · Research Square
  71. Perspective on the Immunotherapy of Pancreatic Cancer
    Bridget P. Keenan, Margaret A. Tempero · 2021 · Cancer immunotherapy
  72. Immune Landscape of Pancreas Ductal Adenocarcinoma: Current Therapeutic Strategies and Future Perspective
    Binbin Zheng-Lin, Eileen Mary O'Reilly · 2021 · Cancer immunotherapy
  73. Harnessing the power of trained immunity in the setting of pancreatic cancer: a novel mechanism of immune trafficking and tumor control.
    Anne E. Geller · 2021
  74. The relevance of Chemistry in Tumor microenvironment of Cancer Patient
    Laureate certified Student Researcher | Davidson Young Scholar., Amisha Gupta · 2021 · Journal of University of Shanghai for Science and Technology
  75. Strategies to Target Tumor Immunosuppression
    Georgia Koutsoumpli, Oana Draghiciu, Hans W. Nijman, César Oyarce, Toos Daemen · 2020 · Springer eBooks
  76. Faculty Opinions recommendation of Obstacles posed by the tumor microenvironment to t cell activity: A case for synergistic therapies.
    George C. Tsokos · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  77. Tumor-Specific CD4 T Cells Instruct Monocyte Differentiation in Pancreatic Ductal Adenocarcinoma
    Michael T. Patterson, Adam L. Burrack, Yingzheng Xu, Zoe C. Schmiechen, Patricia R. Schrank, Ainsley E. Kennedy, Maria M. Firulyova, Ebony A. Miller, Eduardo Cruz-Hinojoza, Konstantin Zaitsev et al. · 2022 · SSRN Electronic Journal
  78. The Tumor Microenvironment in Pancreatic Cancer and Challenges to Immunotherapy
    Adile Orhan · 2022 · Interdisciplinary cancer research
  79. The Prospects of Immunotherapy in Pancreatic Cancer
    Haoqiang Ying, Wantong Yao · 2022 · Springer eBooks
  80. Peer Review #2 of "Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients (v0.1)"
    2023 · PeerJ
  81. Peer Review #1 of "Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients (v0.2)"
    2023 · PeerJ
  82. Peer Review #1 of "Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients (v0.1)"
    2023 · PeerJ
  83. Data from Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
    Sara A. Väyrynen, Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams, Vicente Morales-Oyarvide, Mai Chan Lau, Douglas Adam Rubinson, Richard Francis Dunne et al. · 2023
  84. Data from Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy
    Bradley N. Mills, Haoming Qiu, Michael G. Drage, Chunmo Chen, Jocelyn S. Mathew, Jesse Garrett-Larsen, Jian Ye, Taylor Paige Uccello, Joseph D. Murphy, Brian A. Belt et al. · 2023
  85. Data from Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
    Sara A. Väyrynen, Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams, Vicente Morales-Oyarvide, Mai Chan Lau, Douglas Adam Rubinson, Richard Francis Dunne et al. · 2023
  86. Supplemental Figure 4 from Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations
    Kiah L. Sanders, Barbara A. Fox, David J. Bzik · 2023
  87. Data from Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations
    Kiah L. Sanders, Barbara A. Fox, David J. Bzik · 2023
  88. Data from CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in Mice
    Yaqing Zhang, Wei Yan, Esha Mathew, Filip Bednar, Shanshan Wan, Meredith A. Collins, Rebecca A. Evans, Theodore Hobart Welling, Robert H. Vonderheide, Marina Pasca di Magliano · 2023
  89. Data from Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
    Rafael Winograd, Katelyn T. Byrne, Rebecca A. Evans, Pamela M. Odorizzi, Anders R.L. Meyer, David Lawrence Bajor, Cynthia J. Clendenin, Ben Z. Stanger, Emma Elizabeth Furth, E. John Wherry et al. · 2023
  90. Data from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
    Mark S. Diamond, Jeffrey Lin, Robert H. Vonderheide · 2023
  91. Supplementary Figure S4 from Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
    Rafael Winograd, Katelyn T. Byrne, Rebecca A. Evans, Pamela M. Odorizzi, Anders R.L. Meyer, David Lawrence Bajor, Cynthia J. Clendenin, Ben Z. Stanger, Emma Elizabeth Furth, E. John Wherry et al. · 2023
  92. Impacto da via de sinalização Wnt/-catenina, matriz extracelular e transição epitélio-mesenquimal nas alterações moleculares do estroma em carcinomas pulmonares de não pequenas células
    Camila Machado Baldavira · 2023
  93. Systemic Onco-sphere: Host Adaptive Immune System
    Phei Er Saw, Erwei Song · 2023 · Springer eBooks
  94. Immunotherapy for Pancreatic Cancer
    Arsen Osipov, Adrian Gerard Murphy, Lei Zheng · 2023 · Wiley eBooks
  95. Clinically relevant orthotopic pancreatic cancer models for adoptive T cell therapy
    Natalie K. Horvat, Isaac Karpovsky, Maggie J. Phillips, Megan M. Wyatt, Margaret A. Hall, Cameron J. Herting, Jacklyn Hammons, Zaid K Mahdi, Richard A. Moffitt, Chrystal Mary Paulos et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Pseudolycorine Chloride Ameliorates Th17-cell-mediated CNS Autoimmunity by Restraining MDSCs Expansion
    Gan Zhang, Xinying Zhu, Fan Yang, Juan Li, Xiao Leng, Limei Li, Yantang Wang · 2021 · Research Square
  97. Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreatic cancer
    Uday Kishore, Praveen Mathews Varghese, Alessandro Mangogna, Lukas Klein, Mengyu Tu, Laura Urbach, Mengjie Qiu, Rémy Nicolle, Valarmathy Murugaiah, Nazar Beirag et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Immunotherapy in Pancreatic Cancer
    Zachary Phillip Yeung, Madappa N. Kundranda · 2023 · Springer eBooks
  99. Irreversible electroporation potentiates beta glucan induced trained innate immunity: a novel combination treatment for pancreatic adenocarcinoma.
    Matthew R. Woeste · 2023
  100. Reevaluation of EPO and its Derivatives Centering on β Common Receptor
    Yumin Luo, Rongliang Wang, Zhenhong Yang · 2024